Abstract P6-11-05: Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), in combination with paclitaxel (Pac) in patients (its) with triple negative breast cancer (TNBC)

2017 ◽  
Author(s):  
AM DeMichele ◽  
JJ Harding ◽  
ML Telli ◽  
P Münster ◽  
RR McKay ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Small Molecule ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase 1 ◽  
Small Molecule Inhibitor ◽  
Phase 1 Study ◽  
Molecule Inhibitor

A novel small molecule inhibitor of CD151 inhibits proliferation of metastatic triple negative breast cancer cell lines

2018 ◽  
Vol 66 ◽  
pp. 254-262 ◽  
Author(s):  
Murali Mohan Gavara ◽  
Kunal Zaveri ◽  
Anil Kumar Badana ◽  
Shailender Gugalavath ◽  
Krishna Chaitanya Amajala ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Lines ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Small Molecule ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Small Molecule Inhibitor ◽  
Breast Cancer Cell Lines ◽  
Molecule Inhibitor

scholarly journals EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer

2019 ◽  
Vol 18 (8) ◽  
pp. 1341-1354 ◽  
Author(s):  
Suryavathi Viswanadhapalli ◽  
Yiliao Luo ◽  
Gangadhara R. Sareddy ◽  
Bindu Santhamma ◽  
Mei Zhou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Small Molecule ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Small Molecule Inhibitor ◽  
Molecule Inhibitor
Sign in / Sign up

Export Citation Format

Share Document